Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Abstract Ovarian cancer is the most lethal gynaecologic malignancy. Although there are various subtypes of ovarian cancer, high-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer deaths. Chemoresistance is the primary reason for the unfavourable prognosis of HGSOC. Kallistatin (K...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2019-12-01
|
| Reeks: | Journal of Ovarian Research |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s13048-019-0601-6 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
